MMB Healthcare pharmaceutical group companies are a network of independent associated companies focused on improving patient health and addressing unmet medical needs primarily by acquiring, developing, manufacturing and commercializing specialty pharmaceutical products in niche orphan disease and specialty market segments.

Group pharmaceutical companies include West Therapeutic Development, LLC (Northbrook, IL), BTCP Pharma, LLC, OpRems, LLC - Technology/Software and Lincoln Therapeutics, LLC (Fargo, N.D).

We create new healthcare companies through acquisitions, primarily in the pharmaceutical segment, which includes branded drugs, biologics, biosimilars and generics, then pursue organic growth to create value.


Biopharmaceutical Companies

West Therapeutic Development
Lincoln Therapeutics


Mr. Burke serves as the controlling shareholder and/or Chairman of the Board of the MMB Healthcare network of independent associated healthcare companies including Lincoln Therapeutics, LLC, West Therapeutic Development, LLC, BTCP Pharma and OpRems LLC.

Prior to founding MMB Healthcare Investments, Mr. Burke was one of three founding investors and an operating executive at Marathon Pharmaceuticals, LLC, a specialty pharmaceutical company that acquired, developed, grew and then divested specialty and orphan disease pharmaceutical products.

Prior to Marathon, Mr. Burke was one of the first members of the Ovation Pharmaceuticals’ executive team. As an operating executive he focused on sales, marketing, business development and the assessment of acquisition targets. He became chief commercial officer of Lundbeck Inc. following Lundbeck’s acquisition of Ovation in 2009.

Prior to Ovation, Mr. Burke spent eight years in the Pharmaceuticals Products Division at Abbott Laboratories, where he served in various sales and marketing roles and managed specialty market and primary care product lines.

Mr. Burke holds a B.A. from Providence College and an M.B.A. from the Kellogg School of Management at Northwestern University.

Mr. Borgerding serves as the Vice President, General Counsel & Chief Compliance Officer at the MMB Healthcare network of independent associated healthcare companies.

Prior to MMB Healthcare, Mr. Borgerding served as Vice President, Legal Affairs & Chief Compliance Officer with Assertio Therapeutics, Inc. Prior to Assertio, he was with Lundbeck in legal roles of increasing responsibility including as Vice President, Chief Compliance Officer and Corporate Counsel. Prior to Lundbeck, he was a Senior Counsel at Takeda Pharmaceuticals North America, an Associate at K&L Gates in Washington, DC, and a Regulatory Counsel at the Food and Drug Administration. Mr. Borgerding served with the U.S. Army’s 82nd Airborne Division and deployed in support of Operation Iraqi Freedom in 2003.

Mr. Borgerding earned his J.D. from Valparaiso University School of Law and his BA in Biological Sciences from DePauw University.

Mr. Burke serves as an Executive Board Member of the MMB Healthcare network of independent associated healthcare companies. In this role he provides insight and counsel on mergers and acquisitions as well as directing corporate financing strategy for the various companies.

Mr. Burke is an accomplished finance executive with over 25 years of experience in the real estate, principal investment, private equity, fixed income and investment banking sectors, primarily with Lehman Brothers, Dresdner Kleinwort and Wachovia Securities International, with the last 16 years in London and the prior 10 years in New York.

Mr. Burke has successfully operated in both principal and advisory roles in multiple international jurisdictions. He has completed equity and debt transactions in the real estate; mortgage; infrastructure; sports and media; asset backed operating company sectors raising, financing or investing more than $15 billion in over 50 transactions.

Mr. Burke received a B.A. from Georgetown University in 1988 and an MBA in finance from Columbia University in 1993.

Mr. Burke is based in London.

Ms. Patel serves as the VP of Regulatory Affairs, Clinical Quality Assurance, and Pharmacovigilance for West Therapeutic Development, LLC. Ms. Patel has over 20 years of experience in global regulatory affairs.

Prior to joining MMB Healthcare, Ms. Patel held positions within regulatory affairs in several large and small pharmaceutical companies, including Abbott Laboratories, Pfizer Inc, Ovation/Lundbeck and more recently, Capstone Development, a Water Street Healthcare Partners company.

Ms. Patel holds a B.A. from the University of Illinois.

Dr. Boedeker serves as Medical Director for the MMB Healthcare network of independent associated healthcare companies and is a co-founder of Lincoln Therapeutics LLC. Prior to joining MMB Healthcare, Dr. Boedeker was the Vice Chair for Anesthesia Research at the University of Nebraska Medical Center holding the rank of full professor and staff anesthesiologist at the Omaha VA Medical Center. He is a former military research physician with concentrations in novel analgesic development and telemedicine solutions. His last assignment was serving as IMA to the Commander, Telemedicine and Advanced Technology Research Center (TATRC), Fort Detrick, MD where he retired after 30 years of service holding the rank of Colonel.

Dr. Boedeker earned a Doctorate in Veterinary Medicine at Colorado State University, a PhD in Pathology from Georgetown University, and MD from the John Burns School of Medicine, University of Hawaii, and an MBA from Regis University, Denver, Colorado. He is a graduate of the US Air Force Air War College.